Skip to content

The role of SIRT3 in the pathogenesis of psoriasis

The role of SIRT3 in the pathogenesis of psoriasis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033555
Enrollment
Unknown
Registered
2020-06-05
Start date
2020-06-20
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Interventions

patients with psoriasis vs healthy people:N/A

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 18 and <= 75 years. 2. From June 2020 to February 2021, patients with psoriasis diagnosed by two dermatologists who came to our dermatology department or healthy people who excluded psoriasis and other inflammatory related diseases. 3. The subjects or their legal representatives can fully understand the purpose of the study, and have sufficient compliance with the study plan, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other serious diseases or other life-threatening conditions; 2. Patients who are lack of autonomy, unable to walk or other behaviors are limited; 3. Patients with serious neurological or mental diseases, lactating women or pregnant women.

Design outcomes

Primary

MeasureTime frame
SIRT3 protein level in blood;SIRT3 protein level in skin tissue;

Countries

China

Contacts

Public ContactHui Deng

Shanghai Sixth People's Hospital

hdeng@sjtu.edu.cn+86 18019092005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026